A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

Recruiting now

Conditions studied: Pulmonary Embolism and Thrombosis, Deterioration, Clinical

In brief

This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.

Key facts

Study ID

NCT05098769

Run by

Shengjing Hospital

People needed

300

Starts

2021-01-18

Expected to finish

2026-12-31

Last updated by the study team

2026-03-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography

You may not qualify if…

• pregnancy
• reception of reperfusion treatment before admission
• missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels.

Where it is running

• Shenjing Hospital of CHINA MEDICAL UNIVERSITY — Shenyang, Liaoning, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.